Escalate Capital Partners

Type

Private equity

Status

Active

Location

Austin, United States

Total investments

32

Average round size

17M

Portfolio companies

25

Rounds per year

1.78

Lead investments

2

Follow on index

0.22

Exits

11

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
SoftwareAnalyticsInformation TechnologyHealth CareEnterprise SoftwareManufacturingMarketingPharmaceuticalAdvertisingBiopharma

Summary

In 2005 was created Escalate Capital Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Austin.

Besides them, we counted 3 critical employees of this fund in our database.

Among the various public portfolio startups of the fund, we may underline Kareo, Market Force Information, Ecast Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Software. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Escalate Capital Partners, startups are often financed by OpenView Venture Partners, Intel Capital, El Dorado Ventures. The meaningful sponsors for the fund in investment in the same round are Greenspring Associates, Western Technology Investment, Stripes. In the next rounds fund is usually obtained by Greenspring Associates, JMI Equity, Western Technology Investment.

The fund is constantly included in less than 2 investment rounds annually. This Escalate Capital Partners works on 7 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2012. Despite it in 2019 the fund had an activity.

Show more

Investor highlights

Industry focus
B2B/EnterpriseHealthcare
Check size
5M — 30M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
32
Lead investments
2
Exits
11
Rounds per year
1.78
Follow on index
0.22
Investments by industry
  • Software (15)
  • Marketing (7)
  • Information Technology (7)
  • Health Care (6)
  • Enterprise Software (4)
  • Show 58 more
Investments by region
  • United States (30)
  • Australia (2)
Peak activity year
2012
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
112M
Group Appearance index
0.72
Avg. company exit year
15
Avg. multiplicator
2.77
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Optimize.health 10 Oct 2023 Software, Information Technology, Health Care Early Stage Venture 18M United States, Washington, Seattle

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.